{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:06:14Z","timestamp":1792163174410,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["Bonn International Graduate School of Drug Sciences"],"award-info":[{"award-number":["Bonn International Graduate School of Drug Sciences"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The MAS-related G protein-coupled receptor-X2 (MRGPRX2), an orphan receptor expressed on mast cells (MCs), is upregulated upon inflammation and induces hypersensitivity and inflammatory diseases. In contrast to the large number of MRGPRX2 agonists, only a few antagonists have been described, and no optimization has been reported to improve potency, selectivity, and drug-like properties. Antagonists with ancillary inhibition of the putative mouse ortholog MRGPRB2 have not been described. Here, we present a multi-disciplinary approach involving chemistry, biology, and computational science, resulting in the development of a small-molecule MRGPRX2 antagonist (PSB-172656, 3-ethyl-7,8-difluoro-2-isopropylbenzo[4,5]imidazo [1,2-<jats:italic>a<\/jats:italic>] pyrimidin-4(1<jats:italic>H<\/jats:italic>)-one) based on a fragment screening hit. The compound exhibits metabolic stability, low cytotoxicity, and competitive blockade of MRGPRX2 activation induced by a diverse range of agonists. It displays subnanomolar potency in Ca<jats:sup>2+<\/jats:sup> mobilization assays (<jats:italic>K<\/jats:italic>\n            <jats:sub>i<\/jats:sub> value 0.142\u2009nM) and was found to block MRGPRX2-mediated G\u03b1<jats:sub>q<\/jats:sub> and G\u03b1<jats:sub>i1<\/jats:sub> dissociation, in addition to <jats:italic>\u03b2<\/jats:italic>-arrestin-2 recruitment. PSB-172656 is selective for MRGPRX2 versus all other MRGPRX subtypes. Its effect on MCs was confirmed in cell lines, including rat basophilic leukemia cells (RBL-2H3) recombinantly expressing human MRGPRX2, human Laboratory of Allergic Diseases 2 (LAD2) MCs, and native human skin MCs. PSB-172656 was found to additionally block the putative mouse ortholog of MRGPRX2, MRGPRB2, as determined in Ca<jats:sup>2+<\/jats:sup> mobilization assays (<jats:italic>K<\/jats:italic>\n            <jats:sub>i<\/jats:sub> 0.302\u2009nM), and to prevent mouse tracheal contractions, local allergic reactions, and systemic anaphylactic symptoms. PSB-172656 constitutes a unique pharmacological tool and has the potential to be developed as a drug for mast cell-mediated hypersensitivity reactions and chronic inflammatory diseases, addressing a huge unmet medical need.<\/jats:p>","DOI":"10.1038\/s41392-025-02209-8","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T23:02:27Z","timestamp":1745190147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Subnanomolar MAS-related G protein-coupled receptor-X2\/B2 antagonists with efficacy in human mast cells and disease models"],"prefix":"10.1038","volume":"10","author":[{"given":"Ghazl","family":"Al Hamwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Wessam","family":"Alnouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-2491","authenticated-orcid":false,"given":"Sven","family":"Verdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2794-2941","authenticated-orcid":false,"given":"Piotr","family":"Leonczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-2786","authenticated-orcid":false,"given":"Shaswati","family":"Chaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-7343","authenticated-orcid":false,"given":"Stefan","family":"Frischbutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Kolkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Matthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne K.","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3031-3377","authenticated-orcid":false,"given":"Vigneshwaran","family":"Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Thimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-948X","authenticated-orcid":false,"given":"Andreas E.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-6558","authenticated-orcid":false,"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kota\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-1960","authenticated-orcid":false,"given":"Hydar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Herdewijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"2209_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-7-12","volume":"7","author":"R Pawankar","year":"2014","unstructured":"Pawankar, R. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organ. J. 7, 12 (2014).","journal-title":"World Allergy Organ. J."},{"key":"2209_CR2","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/all.13132","volume":"72","author":"A Muraro","year":"2017","unstructured":"Muraro, A. et al. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-practall document of the european academy of allergy and clinical immunology and the american academy of allergy, asthma and immunology. Allergy 72, 1006\u20131021 (2017).","journal-title":"Allergy"},{"key":"2209_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2500\/aap.2019.40.4274","volume":"40","author":"MC Dispenza","year":"2019","unstructured":"Dispenza, M. C. Classification of hypersensitivity reactions. Allergy Asthma Proc. 40, 470\u2013473 (2019).","journal-title":"Allergy Asthma Proc."},{"key":"2209_CR4","first-page":"637","volume":"71","author":"DG Waller","year":"2011","unstructured":"Waller, D. G. Allergy, pseudo-allergy and non-allergy. Br. J. Pharmacol. 71, 637\u2013638 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"2209_CR5","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/all.15889","volume":"78","author":"M Jutel","year":"2023","unstructured":"Jutel, M. et al. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: an EAACI position paper. Allergy 78, 2851\u20132874 (2023).","journal-title":"Allergy"},{"key":"2209_CR6","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3390\/pharmaceutics13122149","volume":"13","author":"JL Paris","year":"2021","unstructured":"Paris, J. L., de La Torre, P. & Flores, A. I. New therapeutic approaches for allergy: a review of cell therapy and bio- or nano-material-based strategies. Pharmaceutics 13, 2149 (2021).","journal-title":"Pharmaceutics"},{"key":"2209_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/pr.119.018150","volume":"72","author":"MG Matera","year":"2020","unstructured":"Matera, M. G., Page, C. P., Calzetta, L., Rogliani, P. & Cazzola, M. Pharmacology and therapeutics of bronchodilators revisited. Pharmacol. Rev. 72, 218\u2013252 (2020).","journal-title":"Pharmacol. Rev."},{"key":"2209_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.18176\/jiaci.0327","volume":"28","author":"D Gonz\u00e1lez-de-Olano","year":"2018","unstructured":"Gonz\u00e1lez-de-Olano, D. & \u00c1lvarez-Twose, I. Mast cells as key players in allergy and inflammation. J. Investig. Allergol. Clin. Immunol. 28, 365\u2013378 (2018).","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"2209_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000500088","volume":"179","author":"G Varricchi","year":"2019","unstructured":"Varricchi, G. et al. Physiological roles of mast cells: collegium internationale allergologicum update 2019. Int. Arch. Allergy Immunol. 179, 247\u2013261 (2019).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"2209_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nri2018","volume":"7","author":"SC Bischoff","year":"2007","unstructured":"Bischoff, S. C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 7, 93\u2013104 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"2209_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2017.03.003","volume":"184","author":"S Igawa","year":"2017","unstructured":"Igawa, S. & Di Nardo, A. Skin microbiome and mast cells. Transl. Res. 184, 68\u201376 (2017).","journal-title":"Transl. Res."},{"key":"2209_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.immuni.2012.07.003","volume":"37","author":"MF Gurish","year":"2012","unstructured":"Gurish, M. F. & Austen, K. F. Developmental origin and functional specialization of mast cell subsets. Immunity 37, 25\u201333 (2012).","journal-title":"Immunity"},{"key":"2209_CR13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/37.10.2674273","volume":"37","author":"AM Irani","year":"1989","unstructured":"Irani, A. M., Bradford, T. R., Kepley, C. L., Schechter, N. M. & Schwartz, L. B. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37, 1509\u20131515 (1989).","journal-title":"J. Histochem. Cytochem."},{"key":"2209_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12655","volume":"87","author":"K Tatemoto","year":"2018","unstructured":"Tatemoto, K. et al. Endogenous protein and enzyme fragments induce immunoglobulin E-independent activation of mast cells via a G protein-coupled receptor, MRGPRX2. Scand. J. Immunol. 87, e12655 (2018).","journal-title":"Scand. J. Immunol."},{"key":"2209_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1146\/annurev.immunol.17.1.931","volume":"17","author":"JP Kinet","year":"1999","unstructured":"Kinet, J. P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 17, 931\u2013972 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"2209_CR16","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0196-9781(02)00090-6","volume":"23","author":"X Ferry","year":"2002","unstructured":"Ferry, X., Brehin, S., Kamel, R. & Landry, Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 23, 1507\u20131515 (2002).","journal-title":"Peptides"},{"key":"2209_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(01)00483-4","volume":"106","author":"X Dong","year":"2001","unstructured":"Dong, X., Han, S., Zylka, M. J., Simon, M. I. & Anderson, D. J. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106, 619\u2013632 (2001).","journal-title":"Cell"},{"key":"2209_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nn815","volume":"5","author":"PMC Lembo","year":"2002","unstructured":"Lembo, P. M. C. et al. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. 5, 201\u2013209 (2002).","journal-title":"Nat. Neurosci."},{"key":"2209_CR19","doi-asserted-by":"publisher","first-page":"108259","DOI":"10.1016\/j.pharmthera.2022.108259","volume":"238","author":"G Al Hamwi","year":"2022","unstructured":"Al Hamwi, G. et al. MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs. Pharmacol. Ther. 238, 108259 (2022).","journal-title":"Pharmacol. Ther."},{"key":"2209_CR20","first-page":"1322","volume":"349","author":"K Tatemoto","year":"2006","unstructured":"Tatemoto, K. et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem. Biophys. 349, 1322\u20131328 (2006).","journal-title":"Biochem. Biophys."},{"key":"2209_CR21","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1111\/all.14213","volume":"75","author":"B Wedi","year":"2020","unstructured":"Wedi, B., Gehring, M. & Kapp, A. The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: expression and function. Allergy 75, 2229\u20132242 (2020).","journal-title":"Allergy"},{"key":"2209_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaci.2020.12.655","volume":"148","author":"K Wolf","year":"2021","unstructured":"Wolf, K. et al. A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice. J. Allergy Clin. Immunol. 148, 506\u2013522.e8 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2209_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","volume":"134","author":"D Fujisawa","year":"2014","unstructured":"Fujisawa, D. et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J. Allergy Clin. Immunol. 134, 622\u2013633.e9 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2209_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-017-0698-3","volume":"19","author":"W Manorak","year":"2018","unstructured":"Manorak, W. et al. Upregulation of Mas-related G protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1. Respir. Res. 19, 1 (2018).","journal-title":"Respir. Res."},{"key":"2209_CR25","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.jaci.2022.02.021","volume":"149","author":"P Kolkhir","year":"2022","unstructured":"Kolkhir, P. et al. Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo. J. Allergy Clin. Immunol. 149, 1998\u20132009.e5 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2209_CR26","doi-asserted-by":"publisher","first-page":"44400","DOI":"10.1074\/jbc.M302456200","volume":"278","author":"N Robas","year":"2003","unstructured":"Robas, N., Mead, E. & Fidock, M. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J. Biol. Chem. 278, 44400\u201344404 (2003).","journal-title":"J. Biol. Chem."},{"key":"2209_CR27","first-page":"1146","volume":"330","author":"M Kamohara","year":"2005","unstructured":"Kamohara, M. et al. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides. Biochem. Biophys. 330, 1146\u20131152 (2005).","journal-title":"Biochem. Biophys."},{"key":"2209_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu, K. et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat. Chem. Biol. 13, 529\u2013536 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2209_CR29","doi-asserted-by":"publisher","first-page":"44739","DOI":"10.1074\/jbc.M111.277152","volume":"286","author":"H Subramanian","year":"2011","unstructured":"Subramanian, H., Gupta, K., Guo, Q., Price, R. & Ali, H. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization. J. Biol. Chem. 286, 44739\u201344749 (2011).","journal-title":"J. Biol. Chem."},{"key":"2209_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","volume":"19","author":"N Mookherjee","year":"2020","unstructured":"Mookherjee, N., Anderson, M. A., Haagsman, H. P. & Davidson, D. J. Antimicrobial host defence peptides: functions and clinical potential. Nat. Rev. Drug Discov. 19, 311\u2013332 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2209_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s42003-023-05739-5","volume":"7","author":"G Al Hamwi","year":"2024","unstructured":"Al Hamwi, G. et al. Proinflammatory chemokine CXCL14 activates MAS-related G protein-coupled receptor MRGPRX2 and its putative mouse ortholog MRGPRB2. Commun. Biol. 7, 52 (2024).","journal-title":"Commun. Biol."},{"key":"2209_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","volume":"600","author":"C Cao","year":"2021","unstructured":"Cao, C. et al. Structure, function and pharmacology of human itch GPCRs. Nature 600, 170\u2013175 (2021).","journal-title":"Nature"},{"key":"2209_CR33","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","volume":"177","author":"A Inoue","year":"2019","unstructured":"Inoue, A. et al. Illuminating G-protein-coupling selectivity of GPCRs. Cell 177, 1933\u20131947.e25 (2019).","journal-title":"Cell"},{"key":"2209_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000453068","volume":"23","author":"DD Le","year":"2016","unstructured":"Le, D. D. et al. Increase of mast cell-nerve association and neuropeptide receptor expression on mast cells in perennial allergic rhinitis. Neuroimmunomodulation 23, 261\u2013270 (2016).","journal-title":"Neuroimmunomodulation"},{"key":"2209_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4168\/aair.2021.13.3.498","volume":"13","author":"TBT Cao","year":"2021","unstructured":"Cao, T. B. T., Cha, H. Y., Yang, E. M. & Ye, Y. M. Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 13, 498\u2013506 (2021).","journal-title":"Allergy Asthma Immunol. Res."},{"key":"2209_CR36","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.jid.2019.03.404","volume":"139","author":"X Luo","year":"2019","unstructured":"Luo, X., Chen, A., Feng, L. & Wang, H. 328 Expression of MRGPRX2(B2) on mast cells is upregulated in the skin lesion of atopic dermatitis. J. Invest. Dermatol. 139, S57 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"2209_CR37","doi-asserted-by":"publisher","first-page":"e00246","DOI":"10.1128\/IAI.00246-17","volume":"85","author":"K Gupta","year":"2017","unstructured":"Gupta, K. et al. Differential regulation of Mas-related G protein-coupled receptor X2-mediated mast cell degranulation by antimicrobial host defense peptides and porphyromonas gingivalis lipopolysaccharide. Infect. Immun. 85, e00246\u201317 (2017).","journal-title":"Infect. Immun."},{"key":"2209_CR38","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1021\/acsmedchemlett.2c00262","volume":"13","author":"RW Sabnis","year":"2022","unstructured":"Sabnis, R. W. Novel MRGX2 antagonists for treating diseases. ACS Med Chem. Lett. 13, 1006\u20131007 (2022).","journal-title":"ACS Med Chem. Lett."},{"key":"2209_CR39","unstructured":"Brnardic, E. et al. Mrgx2 antagonists. WO2022073904A1 (2022)."},{"key":"2209_CR40","unstructured":"Lanier, M. et al. Modulators of MAS-related G-protein receptor x2 and related products and methods, WO2022067094A1 (2022)."},{"key":"2209_CR41","unstructured":"Cevikbas, F. et al. MRGPRX2 antagonists and uses thereof, WO2021092262 (2022)."},{"key":"2209_CR42","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1124\/mol.111.071472","volume":"79","author":"H Subramanian","year":"2011","unstructured":"Subramanian, H. et al. PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. Mol. Pharm. 79, 1005\u20131013 (2011).","journal-title":"Mol. Pharm."},{"key":"2209_CR43","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.3390\/molecules24234309","volume":"24","author":"P Kirsch","year":"2019","unstructured":"Kirsch, P., Hartman, A. M., Hirsch, A. K. H. & Empting, M. Concepts and core principles of fragment-based drug design. Molecules 24, 4309 (2019).","journal-title":"Molecules"},{"key":"2209_CR44","doi-asserted-by":"publisher","first-page":"15674","DOI":"10.1021\/acs.jmedchem.3c01013","volume":"66","author":"D Marx","year":"2023","unstructured":"Marx, D. et al. Discovery of potent agonists for the predominant variant of the orphan MAS-related G protein-coupled receptor X4 (MRGPRX4). J. Med Chem. 66, 15674\u201315698 (2023).","journal-title":"J. Med Chem."},{"key":"2209_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2018.11.025","volume":"66","author":"Y Ding","year":"2019","unstructured":"Ding, Y. et al. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLC\u03b3-IP3R related Ca2+ fluctuations. Int. Immunopharmacol. 66, 185\u2013197 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"2209_CR46","doi-asserted-by":"publisher","first-page":"129464","DOI":"10.1016\/j.bmcl.2023.129464","volume":"94","author":"P Wollnitzke","year":"2023","unstructured":"Wollnitzke, P. et al. Synthesis and biological evaluation of simplified ajudazol derivatives reveal potent 5-lipoxygenase inhibition and considerable apoptotic activity in neuroblastoma cells. Bioorg. Med. Chem. Lett. 94, 129464 (2023).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2209_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"2209_CR48","doi-asserted-by":"publisher","first-page":"1033794","DOI":"10.3389\/fimmu.2022.1033794","volume":"13","author":"M Bawazir","year":"2022","unstructured":"Bawazir, M., Amponnawarat, A., Hui, Y., Oskeritzian, C. A. & Ali, H. Inhibition of MRGPRX2 but not Fc\u03b5RI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist. Front. Immunol. 13, 1033794 (2022).","journal-title":"Front. Immunol."},{"key":"2209_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jaci.2018.01.043","volume":"142","author":"R Bahri","year":"2018","unstructured":"Bahri, R. et al. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J. Allergy Clin. Immunol. 142, 485\u2013496.e16 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2209_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cca.2022.05.014","volume":"532","author":"DG Ebo","year":"2022","unstructured":"Ebo, D. G. et al. Flow-based allergen testing: can mast cells beat basophils? Clin. Chim. Acta 532, 64\u201371 (2022).","journal-title":"Clin. Chim. Acta"},{"key":"2209_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022559","volume":"6","author":"Q Guo","year":"2011","unstructured":"Guo, Q., Subramanian, H., Gupta, K. & Ali, H. Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases. PLoS E 6, e22559 (2011).","journal-title":"PLoS E"},{"key":"2209_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019585","volume":"6","author":"A Vibhuti","year":"2011","unstructured":"Vibhuti, A., Gupta, K., Subramanian, H., Guo, Q. & Ali, H. Distinct and shared roles of \u03b2-arrestin-1 and \u03b2-arrestin-2 on the regulation of C3a receptor signaling in human mast cells. PLoS ONE 6, e19585 (2011).","journal-title":"PLoS ONE"},{"key":"2209_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","volume":"519","author":"BD McNeil","year":"2015","unstructured":"McNeil, B. D. et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519, 237\u2013241 (2015).","journal-title":"Nature"},{"key":"2209_CR54","doi-asserted-by":"publisher","first-page":"153149","DOI":"10.1016\/j.phymed.2019.153149","volume":"68","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue. Phytomedicine 68, 153149 (2020).","journal-title":"Phytomedicine"},{"key":"2209_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/1087057113475480","volume":"18","author":"C Southern","year":"2013","unstructured":"Southern, C. et al. Screening \u03b2-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J. Biomol. Screen 18, 599\u2013609 (2013).","journal-title":"J. Biomol. Screen"},{"key":"2209_CR56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1177\/1087057108321531","volume":"13","author":"X Zhao","year":"2008","unstructured":"Zhao, X. et al. A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors. J. Biomol. Screen. 13, 737\u2013747 (2008).","journal-title":"J. Biomol. Screen."},{"key":"2209_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF03189651","volume":"9","author":"F Keller","year":"1984","unstructured":"Keller, F., Maiga, M., Neumayer, H. H., Lode, H. & Distler, A. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease. Eur. J. Drug Metab. Pharmacokinet. 9, 275\u2013282 (1984).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"2209_CR58","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","volume":"17","author":"F Zhang","year":"2012","unstructured":"Zhang, F., Xue, J., Shao, J. & Jia, L. Compilation of 222 drugs\u2019 plasma protein binding data and guidance for study designs. Drug Discov. Today 17, 475\u2013485 (2012).","journal-title":"Drug Discov. Today"},{"key":"2209_CR59","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.3390\/cells10112906","volume":"10","author":"H Ogasawara","year":"2021","unstructured":"Ogasawara, H. & Noguchi, M. Therapeutic potential of MRGPRX2 inhibitors on mast cells. Cells 10, 2906 (2021).","journal-title":"Cells"},{"key":"2209_CR60","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/JLB.3MA1219-210RR","volume":"107","author":"A Mencarelli","year":"2020","unstructured":"Mencarelli, A. et al. A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions. J. Leukoc. Biol. 107, 797\u2013807 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"2209_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72819-5","volume":"10","author":"E Hamamura-Yasuno","year":"2020","unstructured":"Hamamura-Yasuno, E., Iguchi, T., Kumagai, K., Tsuchiya, Y. & Mori, K. Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions. Sci. Rep. 10, 16146 (2020).","journal-title":"Sci. Rep."},{"key":"2209_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2017.10.012","volume":"50","author":"E Espinosa","year":"2018","unstructured":"Espinosa, E. & Valitutti, S. New roles and controls of mast cells. Curr. Opin. Immunol. 50, 39\u201347 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"2209_CR63","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.intimp.2013.03.015","volume":"15","author":"TJ Yoon","year":"2013","unstructured":"Yoon, T. J. et al. Inhibitory effect of chaga mushroom extract on compound 48\/80-induced anaphylactic shock and IgE production in mice. Int Immunopharmacol. 15, 666\u2013670 (2013).","journal-title":"Int Immunopharmacol."},{"key":"2209_CR64","doi-asserted-by":"publisher","first-page":"1360296","DOI":"10.3389\/fimmu.2024.1360296","volume":"15","author":"TA Su\u00e1rez V\u00e1zquez","year":"2024","unstructured":"Su\u00e1rez V\u00e1zquez, T. A., L\u00f3pez L\u00f3pez, N. & Salinas Carmona, M. C. MASTer cell: chief immune modulator and inductor of antimicrobial immune response. Front Immunol. 15, 1360296 (2024).","journal-title":"Front Immunol."},{"key":"2209_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrd.2015.18","volume":"15","author":"RA Copeland","year":"2016","unstructured":"Copeland, R. A. The drug-target residence time model: a 10-year retrospective. Nat. Rev. Drug Discov. 15, 87\u201395 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2209_CR66","doi-asserted-by":"publisher","first-page":"803335","DOI":"10.3389\/fimmu.2021.803335","volume":"12","author":"S Chaki","year":"2021","unstructured":"Chaki, S. et al. Inhibition of orai channel function egulates Mas-related G protein-coupled receptor-mediated responses in mast cells. Front. Immunol. 12, 803335 (2021).","journal-title":"Front. Immunol."},{"key":"2209_CR67","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.jid.2022.05.005","volume":"142","author":"S Roy","year":"2022","unstructured":"Roy, S., Alkanfari, I., Chaki, S. & Ali, H. Role of MrgprB2 in rosacea-like inflammation in mice: modulation by \u03b2-arrestin 2. J. Invest. Dermatol. 142, 2988\u20132997.e3 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"2209_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34327-0","volume":"13","author":"A Simon","year":"2022","unstructured":"Simon, A. et al. The endocannabinoid anandamide is an airway relaxant in health and disease. Nat. Commun. 13, 6941 (2022).","journal-title":"Nat. Commun."},{"key":"2209_CR69","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaci.2022.12.805","volume":"151","author":"M Kumar","year":"2023","unstructured":"Kumar, M., Duraisamy, K., Annapureddy, R. R., Chan, C. B. & Chow, B. K. C. Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction. J. Allergy Clin. Immunol. 151, 1110\u20131122 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2209_CR70","doi-asserted-by":"publisher","first-page":"176385","DOI":"10.1016\/j.ejphar.2024.176385","volume":"967","author":"ES Da Brum","year":"2024","unstructured":"Da Brum, E. S., Fialho, M. F. P., Becker, G., Nogueira, C. W. & Oliveira, S. M. Involvement of peripheral mast cells in a fibromyalgia model in mice. Eur. J. Pharm. 967, 176385 (2024).","journal-title":"Eur. J. Pharm."},{"key":"2209_CR71","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"2209_CR72","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng, Y. & Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharm. 22, 3099\u20133108 (1973).","journal-title":"Biochem. Pharm."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02209-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02209-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02209-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T23:02:30Z","timestamp":1745190150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02209-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02209-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M., M.W.A, Y.R., D.T., D.M, V.N., S.G. P.H., S.D.J., P.L., and S.V. are coinventors of the patent US20210128561A1. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human-induced pluripotent stem cells used in this study were derived previously from fibroblasts commercially available at ATCC: CRL-2429 (BIHi001), Lonza: CC-2511(BIHi250-A), and approved by Stanford University (BIHi005-A, approval no. 350\u2013panel 3). The use of skin samples from healthy individuals was conducted with the informed consent of all donors and was approved by the local ethics committee of Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin (EA4\/193\/18; EA1\/155\/24). Animal studies were conducted according to the guidelines of the Declaration of Helsinki and approved by the Local Ethics Committee for Animal Experiments (Cracow, Poland, Permissions No: 932\/2024, date: 25.10.2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"128"}}